Assura Reports Loss For Full Year, But Rental Income Rises

Assura plc (AGR.L), a primary care property investor and developer, Tuesday reported a loss before tax of 119.2 million pounds for the full year, compared with a profit before tax of 155.8 million pounds in the previous year, primarily due to a revaluation deficit.

Net loss for the year was 119.2 million pounds or 4p per share compared with a net profit of 155.9 million pounds or 5.6p per share last year.

EPRA earnings, however, rose to 96.8 million pounds or 3.3p per share pounds from 86.2 million pounds or 3.1p per share a year ago.

Net rental income increased 9.1% to 138 million pounds from 126.5 million pounds last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT